Sign in

shampadaspkpd.bsky.social

@shampadaspkpd.bsky.social
22 followers 29 following 1 posts
PostsRepliesMedia
Reposted by @shampadaspkpd.bsky.social
ESCMID @escmid.bsky.social · 01/10/2025
Spotlight on neonatal sepsis: Of 40 antibiotics approved since 2000, only 4 contained dosing information for neonates. Important challenges from variable PK/PD to regulatory hurdles to funding and building trust with parents. #GAMRIC2025 @carb-x.bsky.social @lifearc.bsky.social @gardp.bsky.social
141
Reposted by @shampadaspkpd.bsky.social
ESCMID @escmid.bsky.social · 01/10/2025
Eva Krockow has entered the chat. Language matters! When clinicians speak to the public about #AMR, be clear & explicit. Drop the acronyms, use jargon-free language & give actionable recs to reach your target audience. #GAMRIC2025 @carb-x.bsky.social @lifearc.bsky.social @gardp.bsky.social #IDSky
051
Reposted by @shampadaspkpd.bsky.social
Trailfinder CF Innovation Hub @cf-trailfinder.bsky.social · 19/09/2025
Interested in learning more about bacterial behaviour? Check out this BBC World Service show 'The Documentary: The social lives of bacteria' featuring our Hub Director Jo Fothergill www.bbc.co.uk/sounds/play/...
bbc.co.uk
The Documentary - The social lives of bacteria - BBC Sounds
The microscopic dramas of bacterial loners, crowd-lovers, backstabbers and do-gooders
021
Reposted by @shampadaspkpd.bsky.social
Research@LivUni @livuniresearch.bsky.social · 27/08/2025
Two Liverpool professors of have received prestigious @royalsociety.org awards 🎉 🎖️Matt Rosseinsky awarded the Royal Medal for Physical Sciences for materials design & discovery 🏅Andy Cooper awarded the Davy Medal for digital chemistry and robotics Full story 👉 news.liverpool.ac.uk/2025/08/27/e...
031
Reposted by @shampadaspkpd.bsky.social
Institute of Systems, Molecular and Integrative Biology @livuni-ismib.bsky.social · 04/07/2025
In an article in The Conversation (@uk.theconversation.com) CELT's Co-Director, Professor Andrew Owen explains everything we need to know about lenacapavir, an injectable drug that offers long-lasting protection against HIV infection. ➡️ bit.ly/3ZZOMQW @livuninews.bsky.social | #TeamLivUni
A news title card that reads ‘US approves twice-yearly injection for HIV prevention – what you need to know about lenacapavir’ in white text against a navy blue background with a transparent image of a needle and a vial.
023
Reposted by @shampadaspkpd.bsky.social
Dan Carr @daniel-f-carr.bsky.social · 04/07/2025
There is still time to apply for our exciting new MSc Precision Medicine programme here @liverpooluni.bsky.social @livunihls.bsky.social @livuni-ismib.bsky.social ! Please scan the QR code for more information, or if you wish to arrange an informal chat, please contact me (d.carr@liverpool.ac.uk).
021
Reposted by @shampadaspkpd.bsky.social
ESCMID @escmid.bsky.social · 12/06/2025
Explore the origins of the brand new #GAMRIC meeting with Erin Duffy, John H. Rex and Robert Skov in this new YouTube Video on the ESCMID channel! youtu.be/u_8VgRZlDiI You can still submit your abstract until tomorrow 13 June 2025! www.gamric.org/programme-ab... #IDSky #clinmicro #AMR
youtu.be
041
Reposted by @shampadaspkpd.bsky.social
ESCMID @escmid.bsky.social · 06/05/2025
Abstract submission and registration are now open for #GAMRIC! Be sure to submit your original abstract before the deadline on 13 June. And with only 300 onsite tickets available, early registration is recommended to guarantee your place. gamric.org #idsky #clinmicro
041
shampadaspkpd.bsky.social @shampadaspkpd.bsky.social · 03/12/2024
We're advertising a fully funded PhD to explore the PK-PD of Phage therapy being developed for the treatment of Cystic Fibrosis lung infections. The post is in the Department of Pharmacology and Therapuetics at the University of Liverpool. @livuni-ismib.bsky.social @jofoth.bsky.social
findaphd.com
Exploring the PK-PD of Phage therapy being developed for the treatment of Cystic Fibrosis lung infections at University of Liverpool on FindAPhD.com
PhD Project - Exploring the PK-PD of Phage therapy being developed for the treatment of Cystic Fibrosis lung infections at University of Liverpool, listed on FindAPhD.com
051